Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):820-2. doi: 10.1158/1055-9965.EPI-05-0864.

Abstract

To test the significance of human papillomavirus (HPV) type 16 and HPV16 E6 variants as risk factors for viral persistence and progression to high-grade lesion, we did a nested case-control study within a cohort study of >15,000 Caucasian French women. Three groups infected with high-risk HPV were compared: (a) women with cleared infection (controls, n = 201), (b) women with persistent infection (cases, n = 87), and (c) women who progressed into high-grade lesion (cases, n = 58). Women with persistent HPV infection and those that progressed into high-grade lesions were likelier to harbor HPV16 than other high-risk HPV types [odds ratio (OR), 2.4; 95% confidence interval (95% CI), 1.3-4.3 and OR, 4.2; 95% CI, 2.2-8.1, respectively]. Notably, especially elevated ORs of persistence (3.0; 95% CI, 1.4-6.7) and progression (6.2; 95% CI, 2.7-14.3) were found among women who harbored the HPV16 350G variant. Thus, HPV type and HPV16 variant seem to be risk factors for viral persistence and progression of infections into high-grade cervical lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Cohort Studies
  • Disease Progression
  • Female
  • France / epidemiology
  • Humans
  • Odds Ratio
  • Oncogene Proteins, Viral / isolation & purification*
  • Papillomavirus Infections / complications*
  • Repressor Proteins / isolation & purification*
  • Risk Factors
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / virology*

Substances

  • E6 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral
  • Repressor Proteins